BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 12827935)

  • 41. Potential use of RNA interference as therapeutic strategy in urologic cancer.
    Green WJ; James PA; Ratan HL
    Urology; 2011 Sep; 78(3):500-4. PubMed ID: 21741681
    [No Abstract]   [Full Text] [Related]  

  • 42. [Cytologic tumor diagnosis in urology].
    Kelâmi A; Kirstaedter HJ
    Z Urol Nephrol; 1969; 62(7):519-27. PubMed ID: 5407745
    [No Abstract]   [Full Text] [Related]  

  • 43. Exfoliative cytology of the urine in tumour diagnosis.
    Puntala P; Koivuniemi A; Sivula A
    Ann Chir Gynaecol Fenn; 1969; 58(1):20-3. PubMed ID: 5392146
    [No Abstract]   [Full Text] [Related]  

  • 44. Flow cytometry in genitourinary malignancies using paraffin-embedded material.
    Stephenson RA
    Semin Urol; 1988 Feb; 6(1):46-52. PubMed ID: 3291045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genitourinary malignancy.
    Leighton J; Clark J; Giantonio B; Ozols R; Hudes G
    Cancer Chemother Biol Response Modif; 1996; 16():524-63. PubMed ID: 8639400
    [No Abstract]   [Full Text] [Related]  

  • 46. [Tumors of the urinary organs in children].
    Kushch NL; Kononuchenko VP; Moskalenko VZ; Tkachenko LI
    Vopr Okhr Materin Det; 1978 Apr; 23(4):32-7. PubMed ID: 664498
    [No Abstract]   [Full Text] [Related]  

  • 47. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK
    Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503
    [No Abstract]   [Full Text] [Related]  

  • 48. A medical oncologist's perspective on the treatment of patients with genitourinary malignancies.
    Sternberg CN
    Urol Oncol; 2009; 27(2):122-5. PubMed ID: 19285223
    [No Abstract]   [Full Text] [Related]  

  • 49. [Immunodiagnosis of urologic tumors].
    Günther M; Friedrich A; Jenssen HL; Werner H; Köhler H; Seyfarth M; Erdmann T
    Z Urol Nephrol; 1977 May; 70(4):225-30. PubMed ID: 331743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnostic errors in urologic tumors].
    Horn G; Baumann W
    Z Urol Nephrol; 1971 Apr; 64(4):256-70. PubMed ID: 5106570
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunopathology--new help for the clinician.
    Fair WR; Cordon-Cardo C
    Semin Urol; 1988 Feb; 6(1):31-45. PubMed ID: 3291044
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the suitability of "cytooncological" examinations for urological diagnosis].
    Swiesiulski S
    Pol Przegl Chir; 1969 Aug; 41(8):Suppl 8a:1132+. PubMed ID: 5343560
    [No Abstract]   [Full Text] [Related]  

  • 53. Current and proposed biologic markers in prostate cancer: 1994.
    Bostwick DG; Qian J
    J Cell Biochem Suppl; 1994; 19():197-201. PubMed ID: 7823592
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunodiagnosis and immunoimaging.
    Fair WR
    Prog Clin Biol Res; 1988; 269():289-311. PubMed ID: 3293066
    [No Abstract]   [Full Text] [Related]  

  • 55. High frequency of promoter methylation of the 14-3-3 sigma and CAGE-1 genes, but lack of hypermethylation of the caveolin-1 gene, in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.
    Kunze E; Schlott T
    Int J Mol Med; 2007 Oct; 20(4):557-63. PubMed ID: 17786288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of seven screening methods in the diagnosis of bladder cancer.
    Sun Y; He DL; Ma Q; Wan XY; Zhu GD; Li L; Luo Y; He H; Yang L
    Chin Med J (Engl); 2006 Nov; 119(21):1763-71. PubMed ID: 17097029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genitourinary tumors in children.
    Duckett JW; Cromie WB; Bongiovanni AM
    Semin Oncol; 1974 Mar; 1(1):71-5. PubMed ID: 4620425
    [No Abstract]   [Full Text] [Related]  

  • 58. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Marshall FF
    J Urol; 2005 Jun; 173(6):1918. PubMed ID: 15879775
    [No Abstract]   [Full Text] [Related]  

  • 59. What's new in urology.
    Schlegel PN
    J Am Coll Surg; 2001 Aug; 193(2):179-201. PubMed ID: 11491449
    [No Abstract]   [Full Text] [Related]  

  • 60. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.